Company Profile
Enovis Corporation, a medical technology company, focuses on developing clinically differentiated solutions in the United States and internationally. It operates through two segments: Prevention and Recovery, and Reconstructive segments. The Prevention and Recovery segment offers rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, electrical stimulators for pain management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions. The Reconstructive segment develops, manufactures, markets, and distributes surgical solutions that restore mobility and improve patient outcomes, which includes a range of differentiated implants, instrumentation, and enabling technologies used in elective and non-elective joint replacement, limb reconstruction, and foot and ankle procedures; and products for the hip, knee, shoulder, elbow, extremity reconstruction and fixation, foot, ankle, and finger, as well as surgical productivity tools. It also manufactures and distributes a range of products which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company distributes its products through independent distributors, direct salespeople, and patients. The company was formerly known as Colfax Corporation. Enovis Corporation was founded in 1995 and is headquartered in Wilmington, Delaware.
Latest News
Enovis to Host Second Quarter 2026 Results Conference Call on August 6th
STAAR Surgical, Globus Medical, Integer Holdings, and Enovis Stocks Trade Down, What You Need To Know
Stocks making big moves this week: HCA Healthcare, UnitedHealth, CrowdStrike, RXO, and Enovis
Enovis (ENOV) Stock Trades Up, Here Is Why
Reflecting On Medical Devices & Supplies - Specialty Stocks’ Q1 Earnings: Integer Holdings (NYSE:ITGR)
| Sector | Healthcare |
| Industry | Medical Devices |
| Website | https://www.enovis.com |
| Audit Risk | 6 |
| Board Risk | 1 |
| Overall Risk | 1 |
| Market Cap | 1.56B |
| Forward P/E | 6.63 |
| Trailing Annual Div. Rate | 0 |
| Trailing Annual Div. Yield | 0.00% |
| Trailing EPS | -19.89 |
| Forward EPS | 4.08 |
| Book Value | 25.66 |
| Price-to-Book | 1.05 |
| Enterprise-to-Revenue | 1.29 |
| Enterprise-to-EBITDA | 7.89 |
| Short Ratio | 6.46 |
| Earnings Date | 08/06/2026 |
| Earnings Call Date | 08/06/2026 |
| Earnings Average | 0.85 |
| Earnings Low | 0.8 |
| Earnings High | 0.9 |
| Revenue Average | 582.45M |
| Revenue Low | 576.00M |
| Revenue High | 590.30M |